Atlas Trials

An Open-Label Study of Naltrexone in Adults With Attention Deficit Hyperactivity Disorder.

Clinical trial NCT01873729 · COMPLETED

Trial details

NCT number
NCT01873729
Sponsor
Massachusetts General Hospital
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Attention Deficit Hyperactivity Disorder
Start date
2013-11-01
Primary completion
2016-06-01
Enrollment
3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.